← Open Payments lookup

TAMARA HALBERSMA: Open Payments

NPI 1548859374 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$939 in 49 payments from 15 companies in 2025. Trend: 2023 $155 · 2024 $594 · 2025 $939

Food & beverage: $939
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$224
Alkermes, Inc.14$203
ABBVIE INC.4$74
Vanda Pharmaceuticals Inc.3$70
Teva Pharmaceuticals USA, Inc.4$70
Almatica Pharma LLC3$62
Janssen Pharmaceuticals, Inc3$48
Otsuka America Pharmaceutical, Inc.2$45
Axsome Therapeutics, Inc.1$33
E.R. Squibb & Sons, L.L.C.1$29

Products named: CAPLYTA, ARISTADA, VRAYLAR, FANAPT, LOREEV XR, REXULTI, SPRAVATO, AUSTEDO XR.

Industry payments across IA — which companies pay providers there.